HI
AMPH icon

HBK Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

HBK Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-51,700
Closed -$981K – 718
2016
Q3 		$981K Buy
51,700
+40,543
+363% +$736K 0.01% 517
2016
Q2 		$180K Buy
+11,157
New +$157K ﹤0.01% 916
2015
Q4 		– Sell
-31,218
Closed -$365K – 967
2015
Q3 		$365K Buy
+31,218
New +$468K ﹤0.01% 820

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HBK Investments's AMPH Position: Q4 2016 in Review

HBK Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2016, closing a stake of 51,700 shares — an estimated $981K sold.

HBK Investments first reported a position in AMPH in Q3 2015 and held it in 3 quarters. The position peaked at $981K in Q3 2016. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

  • HBK Investments reported no remaining Amphastar Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • HBK Investments sold 51,700 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $981K.
  • HBK Investments first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • HBK Investments's Amphastar Pharmaceuticals position peaked at $981K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on HBK Investments's 13F filing for Q4 2016, filed 14 Feb 2017.